The World Congress on Controversies in Neurology

Home
Welcome Note
Committees
Scientific Program
Timetable
Poster Presentations
General Information
Sponsors
Accompanying Persons’ Program
Past & Future CONy Congresses

 
The World Congress on Controversies in Neurology
The World Congress on Controversies in Neurology
 Sponsors   Registration   Accommodation   Contact 

 
Timetable
 
Thursday, September 06, 2007		  
12:00-19:00 Arrival & Registration
16:00-18:00 
Opening Plenary Session
18:00-19:00 Welcome Reception  
Friday, September 07, 2007
Hall A Hall B Hall C
08:30-10:00
Session 1
Multiple Sclerosis (MS)
Sponsored by an
unrestricted grant from
Biogen Idec
Session 6
Management of
Transient Ischemic
Attacks
Session 11
Autoimmune Dementia
10:00-10:30

Coffee Break

10:30-12:30
Session 2
Anti-Interferon
Antibodies
Sponsored by an
unrestricted grant from
TEVA & Sanofi Aventis
Session 7
Intervensions in
Secondary Stroke Prevention
Session 12
10:30-11:30
A Cure for Alzheimer's Disease (AD)
Session 13
11:30-12:30
Treatment of
Cognitive Impairment
12:30-13:30

Lunch Break

13:30-15:30
Session 3
Treatment Strategies
for MS
Sponsored in part by an
unrestricted grant from
Bayer Schering Pharma
Session 8
Management of Acute Stroke
Session 14
Non-Alzheimer
Dementias
15:30-16:00

Coffee Break

 
16:00-18:00
 
Session 4
16:00-17:00
Multiple Sclerosis (MS)
Sponsored in part by an
unrestricted grant from
Merck-Serono
Session 9
Pathogenesis of PD
Sponsored in part by an
unrestricted grant from
Schwarz Pharma
and Orion
Session 15
Mild Cognitive
Impairment
18:00-18:30
Session 5
Free Communications
(MS)
Session 10
Free Communications
(Various Topics)
Session 16
Free Communications
(Various Topics)
       
Saturday, September 08, 2007
 
Hall A
Hall B
 Hall C
08:30-10:00
Session 17
Psychogenic
Neurological
Disorders
Session 20
Autoimmune Disorders Sponsored in part by an unrestricted grant from
Talecris
Session 24
Parkinson’s
Disease (PD): Early Treatment
Sponsored in part by an unrestricted grant from
Merck-Serono
10:00-10:30
Coffee Break
 10:30-12:30
Session 25
Plenary Session
                                                Neuroprotection & Neuroplasticity
                                                         Sponsored by SSNN
12:30-14:30
Session 18
Satellite Lunch Symposium
Sponsored by ELAN
Can Neurodegenerative Diseases be Slowed or Reversed?
Elan’s Look into the Future
14:30-16:00
 
Session 21
Epilepsy
Session 26
Treatment of
Advanced PD
16:00-16:30
Coffee Break
16:30-18:30
Session 19
Free Communications
(Stroke)
 
Session 22
16:30-17:30
Resistant Epilepsy
Session 27
16:30-17:30
Non-Motor
Aspects of PD
Session 23
17:30-18:30
Free Communications
(Various Topics)
Session 28
17:30-18:30
Parkinsonian
Syndromes

Sunday, September 09, 2007		   
Hall A Hall B  
08:30-10:00
Session 29
Dystonia
Sponsored in part by an unrestricted grant from
MERZ
Session 31
Treatment of Migraine:
Beyond Triptans
 
 
10:00-10:30

Coffee Break

  
10:30-12:00  
Session 30
Restless Legs Syndrome
Sponsored in part by an unrestricted grant from Schwarz Pharma
Session 32
10:30-11:10
Free Communications
(MS)
 
Session 33
11:10-12:00
Free Communications
(Various Topics)
12:00-14:00
Session 34
Satellite Lunch Symposium (Lunch Boxes)
Sponsored by Bayer Schering Pharma
Optimisation of Treatment Benefits in Patients with MS:
Exploring the Betaferon Dose-Response Curve
    


 
CREATED BY WEBSTUDIO   

© All Rights Reserved 2006. Comtecmed.com